ANI Pharmaceuticals Inc (ANIP)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -18,522 -7,091 27,015 35,547 18,779 13,381 -5,159 -26,327 -47,896 -67,789 -63,636 -62,819 -42,608 -22,107 -17,238 -15,468 -22,560 -23,760 -20,350 -1,536
Revenue (ttm) US$ in thousands 614,376 555,456 538,953 517,460 486,816 449,394 401,386 358,694 316,385 283,082 251,322 226,092 216,136 212,459 213,377 213,222 208,475 199,189 197,547 203,434
Net profit margin -3.01% -1.28% 5.01% 6.87% 3.86% 2.98% -1.29% -7.34% -15.14% -23.95% -25.32% -27.78% -19.71% -10.41% -8.08% -7.25% -10.82% -11.93% -10.30% -0.76%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-18,522K ÷ $614,376K
= -3.01%

The net profit margin of ANI Pharmaceuticals Inc experienced a downward trend from March 2020 to December 2022, with fluctuations between -0.76% and -27.78%. This indicates that during this period, the company's profitability in relation to its revenue was consistently negative. However, the net profit margin started to improve from March 2023, gradually increasing to 3.86% by December 2023 and further to 5.01% by June 2024. Despite these improvements, the net profit margin declined to -3.01% by December 2024. Overall, ANI Pharmaceuticals Inc showed signs of recovery in profitability after a period of negative margins, but future monitoring of its performance is advised.